These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11432873)

  • 1. Schwannomin isoform-1 interacts with syntenin via PDZ domains.
    Jannatipour M; Dion P; Khan S; Jindal H; Fan X; Laganière J; Chishti AH; Rouleau GA
    J Biol Chem; 2001 Aug; 276(35):33093-100. PubMed ID: 11432873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.
    Neill GW; Crompton MR
    Biochem J; 2001 Sep; 358(Pt 3):727-35. PubMed ID: 11535133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
    Scoles DR; Huynh DP; Morcos PA; Coulsell ER; Robinson NG; Tamanoi F; Pulst SM
    Nat Genet; 1998 Apr; 18(4):354-9. PubMed ID: 9537418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
    Grootjans JJ; Reekmans G; Ceulemans H; David G
    J Biol Chem; 2000 Jun; 275(26):19933-41. PubMed ID: 10770943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.
    Goutebroze L; Brault E; Muchardt C; Camonis J; Thomas G
    Mol Cell Biol; 2000 Mar; 20(5):1699-712. PubMed ID: 10669747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.
    Grootjans JJ; Zimmermann P; Reekmans G; Smets A; Degeest G; Dürr J; David G
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13683-8. PubMed ID: 9391086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDZ tandem of human syntenin: crystal structure and functional properties.
    Kang BS; Cooper DR; Jelen F; Devedjiev Y; Derewenda U; Dauter Z; Otlewski J; Derewenda ZS
    Structure; 2003 Apr; 11(4):459-68. PubMed ID: 12679023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
    Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate.
    Scoles DR; Huynh DP; Chen MS; Burke SP; Gutmann DH; Pulst SM
    Hum Mol Genet; 2000 Jul; 9(11):1567-74. PubMed ID: 10861283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments.
    Zimmermann P; Tomatis D; Rosas M; Grootjans J; Leenaerts I; Degeest G; Reekmans G; Coomans C; David G
    Mol Biol Cell; 2001 Feb; 12(2):339-50. PubMed ID: 11179419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules.
    Schmucker B; Tang Y; Kressel M
    Hum Mol Genet; 1999 Aug; 8(8):1561-70. PubMed ID: 10401006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif.
    Lin D; Gish GD; Songyang Z; Pawson T
    J Biol Chem; 1999 Feb; 274(6):3726-33. PubMed ID: 9920925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane.
    Deguen B; Mérel P; Goutebroze L; Giovannini M; Reggio H; Arpin M; Thomas G
    Hum Mol Genet; 1998 Feb; 7(2):217-26. PubMed ID: 9425229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas.
    Kimura Y; Koga H; Araki N; Mugita N; Fujita N; Takeshima H; Nishi T; Yamashima T; Saido TC; Yamasaki T; Moritake K; Saya H; Nakao M
    Nat Med; 1998 Aug; 4(8):915-22. PubMed ID: 9701243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
    Huynh DP; Pulst SM
    Oncogene; 1996 Jul; 13(1):73-84. PubMed ID: 8700556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different binding motifs in metabotropic glutamate receptor type 7b for filamin A, protein phosphatase 1C, protein interacting with protein kinase C (PICK) 1 and syntenin allow the formation of multimeric protein complexes.
    Enz R; Croci C
    Biochem J; 2003 May; 372(Pt 1):183-91. PubMed ID: 12570872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
    Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
    Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PDZ proteins PICK1, GRIP, and syntenin bind multiple glutamate receptor subtypes. Analysis of PDZ binding motifs.
    Hirbec H; Perestenko O; Nishimune A; Meyer G; Nakanishi S; Henley JM; Dev KK
    J Biol Chem; 2002 May; 277(18):15221-4. PubMed ID: 11891216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
    Schmucker B; Ballhausen WG; Kressel M
    Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
    Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.